Key result
LACBES and LAmbre occluders show comparable 6-month peri-device leak rates to WATCHMAN.
Why the study?
The sealing efficacy and safety of three LAA occluders (WATCHMAN, LAmbre, and LACBES) needed comparison in one-stop procedures combining CA and LAAO for AF.
Do different left atrial appendage occluders (WATCHMAN, LAmbre, LACBES) differ in 6-month peri-device leak rates in atrial fibrillation patients undergoing a one-stop procedure?
Observational (n=231)
No
Do different left atrial appendage occluders (WATCHMAN, LAmbre, LACBES) differ in 6-month peri-device leak rates in atrial fibrillation patients undergoing a one-stop procedure?
Effect estimate: OR 0.62 (95% CI 0.11-2.35)
Absolute Event Rate: 4.1% vs 8.2%
p-value: p=0.500
WATCHMAN, LAmbre, and LACBES occluders demonstrated comparable effectiveness in achieving LAA closure without significant differences in 6-month peri-device leak during a one-stop AF procedure.
Supports device choice flexibility in one-stop AF procedures; leaves open confirmation of equivalence in randomized trials.
Objective To compare the sealing efficacy and safety of three left atrial appendage (LAA) occluders—WATCHMAN, LAmbre, and LACBES—in a one-stop procedure combining catheter ablation (CA) and LAA occlusion (LAAO) for atrial fibrillation (AF). Methods We retrospectively analyzed 231 AF patients undergoing a one-stop procedure, grouped by implanted occluder (WATCHMAN n = 110, LAmbre n = 72, LACBES n = 49). The 6-month peri-device leak (PDL) was compared across devices, and Firth-corrected logistic regression and Cox proportional hazards models were applied for PDL and stroke analyses, respectively, given low event counts. Results Baseline characteristics were comparable across the three groups ( P > 0.05). PDL rates were 8.2% (9/110), 6.9% (5/72), and 4.1% (2/49) for the WATCHMAN, LAmbre, and LACBES groups, respectively, with no statistically significant intergroup differences ( P > 0.05). Multivariate analysis using Firth correction confirmed that device type was not an independent predictor of PDL, after adjusting for clinical risk profiles. However, a higher CHA 2 DS 2 -VASc score was an independent risk factor, whereas older age was a protective factor. No statistically significant differences in DRT or stroke incidence were observed among the devices during the study's follow-up period and with its limited sample size. However, the statistical power for these rare safety endpoints was low, necessitating larger studies to confirm long-term safety comparisons. Conclusion In the context of the one-stop AF procedure, the WATCHMAN, LAmbre, and LACBES occluders demonstrated comparable effectiveness in achieving LAA closure. A high CHA 2 DS 2 -VASc score and younger age may be risk factors for PDL, warranting closer monitoring in these patient subgroups.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2026) conducted an observational in Non-valvular atrial fibrillation (n=231). LACBES left atrial appendage occluder vs. WATCHMAN left atrial appendage occluder was evaluated on Peri-device leak (PDL) ≥ 3 mm at 6 months (OR 0.62, 95% CI 0.11-2.35, p=0.500). The LACBES and LAmbre left atrial appendage occluders demonstrated comparable 6-month peri-device leak rates to the WATCHMAN device in patients undergoing a one-stop atrial fibrillation procedure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: